Skip to main content
. 2021 Aug 21;46:102109. doi: 10.1016/j.redox.2021.102109

Fig. 8.

Fig. 8

Chemical structure of AZD4831 (AstraZeneca), currently in phase II clinical trials, and PF06282999 (Pfizer) did not proceed from Phase I clinical trials [3].